2023. A prospective study to monitor the side effects associated with disease modifying anti rheumatoid drugs in out-patients of tertiary care hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics. 12, 1 (Feb. 2023), 1–7. DOI:https://doi.org/10.61096/ijrpp.v12.iss1.2023.1-7.